Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
Incredible Health Raises $80M Series B, Reaching $1.65 Billion Unicorn Status as the Leader in Healthcare Hiring
Incredible Health, the fastest-growing career marketplace for permanent healthcare workers, today announced it has secured $80 […]
Philadelphia-based Biotech Company AUM LifeTech Awarded $400,000 NCI/NIH Grant to Advance Their Lung Cancer Immunotherapy Program Using RNA-Targeting Gene Therapy with Checkpoint Inhibitors
AUM LifeTech, Inc., a Philadelphia-based preclinical stage biotechnology company, has received a Small Business Innovation Research […]
Orna Therapeutics Raises $221 Million Series B Financing to Advance Circular RNA Platform and Accelerate Programs to the Clinic
Orna Therapeutics, a biotechnology company pioneering a new class of fully engineered circular RNA therapies […]
Remedium Bio Announces Successful $2.3M Expanded Seed Raise
Remedium Bio, Inc., a biotechnology company developing novel gene therapies, today announced that it has […]
Diri Care, a Consumer Health Technology Startup, Closes US$4.3 Million in Seed Funding Co-led by East Ventures and Sequoia Capital India & Southeast Asia’s Surge
Diri Care, a consumer health technology startup, today announced it has closed its oversubscribed seed […]
Nanopath Secures $10 Million in Series A Funding to Develop and Commercialize Point-of-Care Diagnostics for Women's Health
Nanopath Inc., a molecular diagnostics company enabling high-quality molecular testing in minutes, announced today that […]
CA based Evidence Partners to Announce Growth Financing Round
Evidence Partners® Inc., the market leader in AI-enabled literature review automation software and creator of […]
Epigenic Therapeutics Raises $20 Million in Series Angel and Pre-A Funding to Advance Next Generation Gene Editing Therapy
Epigenic Therapeutics Co., Ltd., a frontier biotechnology company dedicated to developing next generation gene editing […]
F2G Announces $70 Million Financing to Advance Development and Commercialization of New Antifungal Agent Olorofim
F2G Ltd, a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies […]
Eleven Therapeutics Announces $22 Million in Seed Funding
Eleven Therapeutics, a biotechnology company leading the AI revolution in nucleic acid therapeutics, announced today […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more